Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates.

IF 2.9 2区医学 Q2 UROLOGY & NEPHROLOGY

Current Urology Reports Pub Date : 2026-04-11 DOI:10.1007/s11934-026-01330-7

Juan Carlos Angulo-Lozano, Alejandro Calvillo-Ramirez, Andres Noyola-Perez, Gabriel Cojuc-Konigsberg, Hector Vaquera-Alfaro, Alec Anceno, Evan Suzman, Luisa F Sanchez-Musi, Claudia F Mendoza Sanchez Ponce, Pavel Pichardo-Rojas, Jonathan Badin-Castro, Parwiz Abrahimi, Douglas S Scherr

引用次数: 0

查看原文本刊更多论文

膀胱癌获得新型全身疗法的不平等：免疫检查点抑制剂和抗体-药物偶联物临床试验的全球分析。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Urology Reports UROLOGY & NEPHROLOGY-

CiteScore

4.60

自引率

3.80%

发文量

期刊介绍： This journal intends to review the most important, recently published findings in the field of urology. By providing clear, insightful, balanced contributions by international experts, the journal elucidates current and emerging approaches to the care and prevention of urologic diseases and conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as benign prostatic hyperplasia, erectile dysfunction, female urology, and kidney disease. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.